Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose of Lapatinib with
Carboplatin AUC 6 in patients with platinum sensitive recurrent ovarian or primary peritoneal
carcinoma and to determine the nature and degree of toxicity of Lapatinib in combination with
carboplatin AUC 6 in this cohort of patients.